CF Industries Holdings, Inc. (CF) stock analysis
Close on Nov 11, 2026Market cap $18.65BP/E 8.7Yield 1.62%
StockData Score
Prices as of Nov 11, 2026How the score works
Solid17 of 30 checks passed
CF Industries passes 17 of the 30 checks behind our score; 7 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 5/6
- Growth
- 3/6
- Past performance
- 1/6
- Financial health
- 5/6
- Dividend
- 3/6
What stands out
Margin of safety over 20%
The price is 49.5% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $123.24 is below our fair value estimate of $243.91.
Return on capital over 10%
Return on invested capital was 37.6%, above the 10% that usually covers the cost of capital.
Interest well covered
Operating income covers interest expense 11.1 times.
What to watch
High debt
Debt is 56.1% of shareholders' equity, above the 40% we consider low.
Revenue growing under 10% a year
Revenue grew -14.1% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -18.2% a year over the last three fiscal years.
P/B above the industry
CF Industries's price-to-book of 3.25 is above the Chemicals and Allied Products median of 2.25.
Valuation5/6
P/E below its 5-year median
CF Industries's P/E of 8.7 is below its own 5-year median of 10.9.
P/E below the industry
CF Industries's P/E of 8.7 is below the Chemicals and Allied Products median of 25.2.
EV/EBITDA below its 5-year median
CF Industries's EV/EBITDA of 5.8 is below its 5-year median of 6.4.
P/B above the industry
CF Industries's price-to-book of 3.25 is above the Chemicals and Allied Products median of 2.25.
Trading below fair value
The share price of $123.24 is below our fair value estimate of $243.91.
Margin of safety over 20%
The price is 49.5% below fair value, more than the 20% cushion we look for.
Growth3/6
Revenue growing under 10% a year
Revenue grew -14.1% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -18.2% a year over the last three fiscal years.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing faster than the industry
Revenue grew 17.9% over the last twelve months; the Chemicals and Allied Products median is 3.5%.
Guidance raised
CF Industries raised its full year 2026 capital expenditures outlook on May 6, 2026.
Gross margin improving
Gross margin was 42.5% over the last twelve months, against 36.9% a year earlier.
Past performance1/6
Return on equity
Needs positive equity and five years of results.
Return on capital over 10%
Return on invested capital was 37.6%, above the 10% that usually covers the cost of capital.
Return on equity against the industry
Needs positive equity.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin against its history
Needs five years of revenue and net income.
Net margin against the industry
Needs revenue and net income.
Financial health5/6
High debt
Debt is 56.1% of shareholders' equity, above the 40% we consider low.
Debt falling against equity
Debt to equity fell from 136% five years ago to 56.1%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 95.8% of total debt.
Interest well covered
Operating income covers interest expense 11.1 times.
Short-term assets cover short-term debts
Current assets are 2.98 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 3.38; above 3 is the safe zone and below 1.8 the distress zone.
Dividend3/6
Pays a dividend
CF Industries paid dividends worth 1.7% of the share price over the last twelve months.
Yield below Treasuries
The 1.7% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; CF Industries yields 1.7%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Earnings cover
Needs dividends paid and net income.
Covered by free cash flow
Dividends take 15.6% of free cash flow.
Fair value
How we estimate itOur estimate per share
$243.91
The share price is 49% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 18.0× | 10.9× | 25.2× | $255.17 | 40% |
| EV/EBITDA | 11.4× | 6.4× | 16.6× | $301.17 | 35% |
| P/B | 2.7× | 3.1× | 2.3× | $101.80 | 10% |
| Earnings power | 7.4% cost of equity | – | – | $175.04 | 15% |
| Fair value | $243.91 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 10.9
- Chemicals and Allied Products median 25.2
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $275.22M
- Value traded per 1% price move
- $177.75M
Downside
Medium risk
- Typical loss in a bad month
- 16.4%
- Volatility (annualized)
- 44%
- Sharpe ratio, 1 year
- 1.02
- Beta to the S&P 500 (5Y)
- 0.15
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +19.3% | -14.1% | +11.4% | +5.1% | |
| Gross profit | +32.5% | -22.5% | +27.7% | +5.8% | |
| Operating income | +31.7% | -24.7% | +29.9% | +6.8% | |
| EPS, diluted | +33.1% | -18.2% | +43.6% | +11.7% | |
| Free cash flow | +2.8% | -19.1% | +14.3% | – | |
| Dividend per share | 0.0% | +10.1% | +10.8% | +5.2% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Current ratio | 3.87 | 1.51 | 3.37 | |
| Debt to equity | 1.73 | 1.36 | 0.66 | |
| Net debt to EBITDA | 5.65× | 2.16× | 0.81× | |
| Interest coverage | 0.7× | 3.5× | 14.8× | |
| Inventory turnover | 8.6× | 10.4× | 12.5× | |
| Capex to revenue | 60.0% | 7.5% | 13.4% | |
| Diluted shares | 233M | 215M | 162M |
Where the cash went
Fiscal 2021 to 2025, five years combined
CF Industries generated $14.51B from operations and spent $9.84B on capital expenditure, dividends and share buybacks. 30% of that went back into the business.
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero–
- Cash generatingOperating cash flow above zero$2.75B
- Return on assets improvedROA up on the prior year– → –
- Earnings backed by cashOperating cash flow above net income$2.75B vs –
- Less leverageLong-term debt to assets fell22.1% → 22.8%
- Better liquidityCurrent ratio rose3.08 → 3.37
- No dilutionShare count did not rise181M → 162M
- Gross margin improvedGross margin up on the prior year34.64% → 38.45%
- More efficientAsset turnover rose0.41 → 0.53
See a number that looks wrong?